CNX-774BTK inhibitor, orally active, irreversible and selective |
Sample solution is provided at 25 µL, 10mM.
Quality Control & MSDS
- View current batch:
- Purity = 98.00%
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
Chemical structure
CNX-774 Dilution Calculator
calculate
CNX-774 Molarity Calculator
calculate
Cas No. | 1202759-32-7 | SDF | Download SDF |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide | ||
Canonical SMILES | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)F | ||
Formula | C26H22FN7O3 | M.Wt | 499.5 |
Solubility | Soluble in DMSO | Storage | Store at -20°C |
Shipping Condition | Evaluation sample solution : ship with blue ice.All other available size:ship with RT , or blue ice upon request | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. |
CNX-774 is an orally active and selective inhibitor of BTK with IC50 value of <1>1>
Bruton’s tyrosine kinase (BTK) is an important enzyme in the B-cell antigen receptor (BCR) signaling pathway and also plays an important role in mast cell activation and B cell maturation.
CNX-774 is an orally active, irreversible and selective BTK inhibitor with IC50 value of <1 nm.="" cnx-774="" formed="" covalent="" bond="" with="" the="" cys481="" residue="" within="" the="" atp="" binding="" site="" of="" btk.="" in="" cellular="" assays,="" cnx-774="" inhibited="" btk="" with="" ic50="" values="" of="" 1-10="" nm="" [1].="">1>
Reference:[1]. Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol, 2013, 6: 59.